FI
FI · FI · FI-REL-REL57044
Breyanzi
ATC L01XL08
Last synced from Fimea (Finland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG
CountryFI (FI)
ATC codeL01XL08
Dispensing—
ReimbursedNo
SourceFimea (Finland)
Last synced6/14/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"ddd": null,
"form": "infuusioneste, dispersio",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "1.1–70 x 10exp6 solua (CD8)/ml / 1.1–70 x 10exp6 solua (CD4)/ml",
"atc_label": "lisokabtageenimaraleuseeli",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/22/1631/001",
"fimea_rel_id": "REL57044",
"authorised_at": "2022-07-06"
}Related drugs
Other records sharing ATC code L01XL08.
- NOBreyanziBristol-Myers Squibb Pharma EEIG
- ISBreyanziBristol-Myers Squibb Pharma EEIG*
- PLBreyanziBristol-Myers Squibb Pharma EEIG
- BEBreyanziBristol-Myers Squibb Pharma
- DKBreyanziBristol-Myers Squibb Pharma EEIG
- CABREYANZIBRISTOL-MYERS SQUIBB CANADA
- CZBREYANZIBristol-Myers Squibb Pharma EEIG, Dublin
- NLBreyanzi >= 5.1 x 10^6 cellen [CD4 component], suspensie voor injectieCelgene Europe B.V.
Access this data programmatically
Query Breyanzi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.